Gavestinel Does Not Improve Outcome After Acute Intracerebral Hemorrhage

Abstract

These observations from the combined GAIN International and GAIN Americas trials suggest that gavestinel is not of substantial benefit or harm to patients with primary intracerebral hemorrhage. These findings are similar to results previously reported in patients with ischemic stroke.